Welcome to our dedicated page for Allbirds SEC filings (Ticker: BIRD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allbirds, Inc. (NASDAQ: BIRD) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8-K, annual and quarterly reports, and other filings that explain Allbirds’ financial condition, governance and material events.
Allbirds uses Form 8-K to report items such as quarterly financial results, board changes and listing-related matters. For example, the company has filed 8-Ks to furnish earnings press releases for specific quarters, to disclose the appointment or resignation of directors and related committee assignments, and to describe its status with respect to Nasdaq listing rules. These current reports can help investors track developments in areas like board composition, independent director requirements and corporate governance structures.
In its periodic reports, Allbirds discusses metrics such as net revenue, gross margin, net loss and adjusted EBITDA, along with narrative explanations of channel mix, international distributor transitions, retail store closures and cost structure. The company also provides definitions and reconciliations for non-GAAP measures like adjusted EBITDA and adjusted EBITDA margin, outlining which expenses and non-cash items are excluded from these calculations.
Through this filings page, users can review Allbirds’ SEC documents alongside AI-powered summaries that clarify key points from lengthy reports. This includes quick views of quarterly results in Forms 10-Q, annual disclosures in Forms 10-K, and current reports in Forms 8-K, as well as access to information relevant to governance and listing compliance. For those researching BIRD stock, the filings offer a primary source for understanding how Allbirds presents its financial performance, risk factors and corporate actions in an official regulatory context.
Allbirds, Inc. (BIRD) furnished quarterly results via an 8-K, stating it reported financial results and business highlights for the quarter ended September 30, 2025. The earnings press release is attached as Exhibit 99.1.
The information under Item 2.02 is being furnished and is not deemed filed under the Exchange Act, and it is incorporated by reference only if specifically referenced in future filings.
Allbirds (BIRD) appointed Lily Yan Hughes to its board of directors, effective October 31, 2025. She will serve as a Class I director and stand for reelection at the 2028 annual meeting.
Hughes joins the Sustainability, Nomination and Governance Committee and the Management Compensation and Leadership Committee, and will chair the Sustainability, Nomination and Governance Committee. On her start date, she received an initial restricted stock unit award with a grant date fair value of $200,000 under the 2021 Equity Incentive Plan, vesting under the company’s Non‑Employee Director Compensation Policy. She will also receive standard cash retainers and has executed the company’s standard indemnification agreement. The company disclosed no related‑party relationships.
Allbirds, Inc. reported that on September 8, 2025 a director, Ms. Freeman, resigned, leaving the board without a majority of independent directors as defined under Nasdaq Listing Rule 5605(a)(2). The company notified the Nasdaq Global Select Market of the resulting non-compliance with Nasdaq Listing Rule 5605(b)(1). Nasdaq provides a cure period that allows the company to regain compliance before the earlier of one year from September 8, 2025 or the next annual meeting. The filing incorporates related information from Item 3.01 by reference.
Allbirds, Inc. (BIRD) Chief Financial Officer Ann Mitchell sold 2,188 shares of Class A common stock on 09/03/2025 at a weighted average price of $6.37 per share to satisfy tax withholding for vested restricted stock units. After the reported sale, the filing shows Ms. Mitchell beneficially owned 78,498 shares, held directly. The filing clarifies the sale was a "sell to cover" transaction to fund tax obligations and that the shares were sold in multiple transactions at prices ranging from $6.3601 to $6.41.
Allbirds, Inc. (BIRD) reporting person Joseph Vernachio, who is identified as both a Director and Chief Executive Officer, sold shares on 09/03/2025 to satisfy tax withholding related to the vesting and settlement of restricted stock units. The Form 4 shows a reported sale of 3,666 shares of Class A common stock at a weighted average price of $6.37 per share (individual transaction prices ranged from $6.32 to $6.38). After the reported disposition, the reporting person beneficially owned 94,366 shares. The filing states the sales were "sell to cover" transactions to satisfy tax withholding obligations and were not discretionary trades by the reporting person.
Allbirds, Inc. insider or controlled person filed a Form 144 to notify a proposed sale of 3,666 common shares, with an aggregate market value of $23,354, to be sold through Charles Schwab & Co., Inc. on or about 09/03/2025 on NASDAQ. The filing states the shares were acquired on 09/03/2025 upon lapse of restricted stock and are part of equity compensation. The filer also reported a prior sale on 06/03/2025 of 4,450 shares for gross proceeds of $31,800. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.
Allbirds, Inc. (BIRD) Form 144 shows a proposed sale of 2,188 shares of common stock through Charles Schwab & Co., Inc. on 09/03/2025 with an aggregate market value of $13,928.00 and a total outstanding share count listed as 5,604,113. The securities were acquired as an equity compensation event described as a restricted stock lapse on 09/03/2025. The filer previously sold 2,146 shares on 06/03/2025 for gross proceeds of $15,273.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.